Double Medical(SZ:002901) Sou Hu Cai Jing·2025-09-17 13:52Core Viewpoint - The stock of Dabo Medical (002901) has shown a decline in price and significant net outflow of main funds, indicating potential concerns among institutional investors [1][2]. Group 1: Stock Performance - As of September 17, 2025, Dabo Medical's stock closed at 54.66 yuan, down 0.53% with a turnover rate of 0.87% and a trading volume of 25,100 hands, resulting in a transaction amount of 138 million yuan [1]. - Over the past five days, the stock has experienced fluctuations, with a notable net outflow of main funds amounting to 1,966.24 million yuan on September 17, representing 14.28% of the total transaction amount [2]. Group 2: Financial Metrics - Dabo Medical's total market capitalization is 22.63 billion yuan, with a net asset value of 3.233 billion yuan and a net profit of 244 million yuan, ranking 12th, 45th, and 17th respectively in the medical device industry [3]. - The company reported a year-on-year revenue increase of 25.55% to 1.21 billion yuan and a net profit increase of 76.69% to 244 million yuan for the first half of 2025 [3]. - The gross profit margin stands at 71.01%, significantly higher than the industry average of 51.85%, indicating strong profitability [3]. Group 3: Investment Sentiment - In the last 90 days, only one institution has provided a rating for Dabo Medical, with a buy rating issued [4].